Evi X Stavrou1,2. 1. Department of Medicine, Louis Stokes Veterans Administration Medical Center. 2. Department of Medicine, Hematology and Oncology Division, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Abstract
PURPOSE OF REVIEW: This review describes the contribution of coagulation factor XII (FXII) in sterile inflammation and wound healing, focusing on recently identified roles for zymogen FXII in neutrophil functions. RECENT FINDINGS: Recent studies have identified an important role for FXII in neutrophil trafficking. In particular, following neutrophil activation, autocrine FXII signals through the urokinase plasminogen activator receptor (uPAR) on the neutrophil surface to upregulate neutrophil functions. The sum of these activities leads to neutrophil adhesion, chemotaxis, and neutrophil extracellular (NET) formation. Downregulating FXII-mediated signaling in neutrophils is associated with improved wound healing. SUMMARY: These recent findings show the sophisticated role of FXII in vivo and create new opportunities for research on the treatment of chronic inflammatory diseases.
PURPOSE OF REVIEW: This review describes the contribution of coagulation factor XII (FXII) in sterile inflammation and wound healing, focusing on recently identified roles for zymogen FXII in neutrophil functions. RECENT FINDINGS: Recent studies have identified an important role for FXII in neutrophil trafficking. In particular, following neutrophil activation, autocrine FXII signals through the urokinase plasminogen activator receptor (uPAR) on the neutrophil surface to upregulate neutrophil functions. The sum of these activities leads to neutrophil adhesion, chemotaxis, and neutrophil extracellular (NET) formation. Downregulating FXII-mediated signaling in neutrophils is associated with improved wound healing. SUMMARY: These recent findings show the sophisticated role of FXII in vivo and create new opportunities for research on the treatment of chronic inflammatory diseases.
Authors: Ingrid Stroo; Sacha Zeerleder; Chao Ding; Brenda M Luken; Joris J T H Roelofs; Onno J de Boer; Joost C M Meijers; Francis J Castellino; Cornelis van 't Veer; Tom van der Poll Journal: Thromb Haemost Date: 2017-05-11 Impact factor: 5.249
Authors: Joke Konings; José W P Govers-Riemslag; Helen Philippou; Nicola J Mutch; Julian I Borissoff; Peter Allan; Sumitra Mohan; Guido Tans; Hugo Ten Cate; Robert A S Ariëns Journal: Blood Date: 2011-08-09 Impact factor: 22.113
Authors: Gretchen A LaRusch; Fakhri Mahdi; Zia Shariat-Madar; Gregory Adams; Robert G Sitrin; Wan Ming Zhang; Keith R McCrae; Alvin H Schmaier Journal: Blood Date: 2010-03-12 Impact factor: 22.113
Authors: Areez Shafqat; Saleha Abdul Rab; Osama Ammar; Sulaiman Al Salameh; Anas Alkhudairi; Junaid Kashir; Khaled Alkattan; Ahmed Yaqinuddin Journal: Front Med (Lausanne) Date: 2022-08-23
Authors: Alan E Mast; Alisa S Wolberg; David Gailani; Michael R Garvin; Christiane Alvarez; J Izaak Miller; Bruce Aronow; Daniel Jacobson Journal: Elife Date: 2021-03-08 Impact factor: 8.140